Patient compliance with beta‐blocker medication in general practice
- 1 September 1994
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 3 (5) , 251-256
- https://doi.org/10.1002/pds.2630030503
Abstract
We measured compliance with beta‐blocking drugs in a group of 105 patients with uncomplicated hypertension, and without coronary heart disease or other major concomitant disease. We measured compliance with an electronic monitor (MEMS®) that records time and date of each opening of the container in which the patient's regularly prescribed beta blocker was dispensed. This measurement was compared with their physicians' estimates of their compliance with the prescribed beta blocker regimen. Patients were followed during a period of 2–6 months, for a total of 15,274 days of observation. In 820 (5.4 per cent) of observation days dosing was incorrect; in 619 days, one or more tablets were omitted, and in 201 days one or more extra doses were taken. In 64 of the 105 patients, we observed drug holidays: days without evidence of beta blocker dosing. Concordance was low between the physicians' estimates and MEMS‐measured compliance, with a tendency toward physician overestimation of compliance. The study enrolled only patients long treated for uncomplicated disease, with no other serious concomitant illness; this special selection probably accounts for the relatively good compliance found.Keywords
This publication has 16 references indexed in Scilit:
- The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- Measurement of patient compliance and the interpretation of randomized clinical trialsEuropean Journal of Clinical Pharmacology, 1991
- Dynamics of drug regimen compliance ? its assessment by microprocessor-based monitoringEuropean Journal of Clinical Pharmacology, 1990
- The Relative Risk of Incident Coronary Heart Disease Associated With Recently Stopping the Use of β-BlockersJAMA, 1990
- Impact of Unrecognized Dosing Errors on the Cost and Effectiveness of PharmaceuticalsDrug Information Journal, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Circadian Variation in the Frequency of Onset of Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Comparison of withdrawal phenomena after propranolol, metoprolol, and pindololAmerican Heart Journal, 1982
- Measurement of Medication Compliance in a Clinical SettingArchives of internal medicine (1960), 1979